Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes
- PMID: 2448392
- DOI: 10.1111/1523-1747.ep12462239
Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes
Abstract
The prevalence of autoantibodies of immunoglobulin G (IgG) and immunoglobulin M (IgM) classes directed against myeloma immunoglobulin E (IgE) were determined in distinct subsets of urticaria, using an enzyme immunoassay. IgG anti-IgE antibodies were found in five of nine patients (55%) with cold urticaria, four of eight patients (50%) with urticarial vasculitis, and three of six patients (50%) with chronic urticaria. IgM anti-IgE antibodies were found exclusively in cold urticaria (two of nine patients, 22%). Heating of these sera increased the binding to IgE, suggesting immune complex formation. Several positive sera were capable of inducing histamine release from normal peripheral basophils and caused a wheal-flare response upon intradermal injection. Sera containing such autoantibodies from three cold urticaria patients were studied for passive transfer of cold sensitivity. One serum containing IgG anti-IgE gave a strongly positive transfer test at 5 h but not 48 h, suggesting a pathogenic role for the IgG.
Similar articles
-
Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria.Clin Exp Allergy. 1991 Nov;21(6):695-704. doi: 10.1111/j.1365-2222.1991.tb03198.x. Clin Exp Allergy. 1991. PMID: 1723343
-
Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria.J Allergy Clin Immunol. 2000 Sep;106(3):567-72. doi: 10.1067/mai.2000.108913. J Allergy Clin Immunol. 2000. PMID: 10984379
-
Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.J Invest Dermatol. 1996 May;106(5):1001-6. doi: 10.1111/1523-1747.ep12338544. J Invest Dermatol. 1996. PMID: 8618029
-
Pathogenesis of chronic urticaria.Clin Exp Allergy. 2009 Jun;39(6):777-87. doi: 10.1111/j.1365-2222.2009.03256.x. Epub 2009 Apr 22. Clin Exp Allergy. 2009. PMID: 19400905 Review.
-
Autoimmunity in chronic urticaria and urticarial vasculitis.Curr Allergy Asthma Rep. 2001 Jul;1(4):329-36. doi: 10.1007/s11882-001-0044-0. Curr Allergy Asthma Rep. 2001. PMID: 11892055 Review.
Cited by
-
Treatment of chronic spontaneous urticaria.Allergy Asthma Immunol Res. 2012 Nov;4(6):326-31. doi: 10.4168/aair.2012.4.6.326. Epub 2012 May 14. Allergy Asthma Immunol Res. 2012. PMID: 23115728 Free PMC article.
-
Neonatal Fc receptor (FcRn) and maternal-to-newborn IgE absorption.Clin Exp Allergy. 2012 Dec;42(12):1656-9. doi: 10.1111/cea.12018. Clin Exp Allergy. 2012. PMID: 23181783 Free PMC article. No abstract available.
-
Biologic agents in the treatment of urticaria.Curr Allergy Asthma Rep. 2012 Aug;12(4):288-91. doi: 10.1007/s11882-012-0268-1. Curr Allergy Asthma Rep. 2012. PMID: 22740008 Review.
-
Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications.Intern Emerg Med. 2010 Apr;5(2):97-101. doi: 10.1007/s11739-009-0333-5. Epub 2009 Dec 1. Intern Emerg Med. 2010. PMID: 19949893 Review.
-
Expert consensus on the use of omalizumab in chronic urticaria in China.World Allergy Organ J. 2021 Dec 5;14(11):100610. doi: 10.1016/j.waojou.2021.100610. eCollection 2021 Nov. World Allergy Organ J. 2021. PMID: 34934470 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical